Despite the increasing prevalence of the nosocomial pathogen Acinetobacter baumannii, little is known about which genomic components contribute to clinical presentation of this important pathogen. Most whole-genome comparisons of A. baumannii have focused on specific genomic regions associated with phenotypes in a limited number of genomes. In this work, we describe the results of a whole-genome comparative analysis of 254 surveillance isolates of Acinetobacter species, 203 of which were A. baumannii, isolated from perianal swabs and sputum samples collected as part of an infection control active surveillance program at the University of Maryland Medical Center. The collection of surveillance isolates includes both carbapenem-susceptible and -resistant isolates. Based on the whole-genome phylogeny, the A. baumannii isolates collected belong to two major phylogenomic lineages. Results from multilocus sequence typing indicated that one of the major phylogenetic groups of A. baumannii was comprised solely of strains from the international clonal lineage 2. The genomic content of the A. baumannii isolates was examined using large-scale BLAST score ratio analysis to identify genes that are associated with carbapenem-susceptible and -resistant isolates, as well as genes potentially associated with the source of isolation. This analysis revealed a number of genes that were exclusive or at greater frequency in each of these classifications. This study is the most comprehensive genomic comparison of Acinetobacter isolates from a surveillance study to date and provides important information that will contribute to our understanding of the success of A. baumannii as a human pathogen.
The Acinetobacter genus is comprised of 34 named species, many of which are found ubiquitously in the environment (1). The most clinically relevant species are members of what is known as the Acinetobacter calcoaceticus-baumannii (Acb) complex, which include A. baumannii, A. nosocomialis, A. pittii, and A. calcoaceticus (2). The organisms of the Acb complex are difficult to distinguish from each other using traditional culturing and molecular diagnostic methods employed in the current clinical microbiology laboratories (3). A. baumannii is the most frequently isolated Acinetobacter species in the health care setting (4), partly due to its ability to survive on abiotic surfaces for long periods of time (5), as well as its ability to rapidly develop antibiotic resistance (6). It is an important emerging nosocomial pathogen associated with common infections, multidrug resistance, and a high transmission rate within hospitals all over the world (7).Prior genomic studies of A. baumannii have mainly focused on multidrug-resistant strains and have identified key determinants associated with resistance (8-14). A genomic comparison of six clinical isolates of A. baumannii concluded that despite extensive genome-wide similarity, the resistance gene repertoire was highly variable, even in the genomically closely related isolates (10). In addition, anothe...